Biomarin Pharmaceutical Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,423,712

Value ($000)

84,611

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	84,611	0.0%	1,423,712	12/31/2025
2025 Q3	11/10/2025	75,694	0.0%	1,397,600	9/30/2025
2025 Q2	8/12/2025	85,540	0.0%	1,556,117	6/30/2025
2025 Q1	9/15/2025	108,319	0.0%	1,532,314	3/31/2025
2024 Q4	2/6/2025	93,567	0.0%	1,423,508	12/31/2024
2024 Q3	11/12/2024	98,520	0.0%	1,401,628	9/30/2024
2024 Q2	8/12/2024	110,810	0.0%	1,345,929	6/30/2024
2024 Q1	5/9/2024	117,150	0.0%	1,341,315	3/31/2024
2023 Q4	2/6/2024	132,953	0.0%	1,378,897	12/31/2023
2023 Q3	11/8/2023	115,448	0.0%	1,304,797	9/30/2023
2023 Q2	8/10/2023	110,188	0.0%	1,271,205	6/30/2023
2023 Q1	5/12/2023	122,428	0.0%	1,259,032	3/31/2023
2022 Q4	2/13/2023	128,533	0.0%	1,241,980	12/31/2022
2022 Q3	11/14/2022	102,998	0.0%	1,215,017	9/30/2022
2022 Q2	8/15/2022	99,620	0.0%	1,202,110	6/30/2022
2022 Q1	5/13/2022	86,972	0.0%	1,128,030	3/31/2022
2021 Q4	2/11/2022	97,268	0.0%	1,100,939	12/31/2021
2021 Q3	11/16/2021	81,264	0.0%	1,051,404	9/30/2021
2021 Q2	8/16/2021	51,426	0.0%	616,320	6/30/2021
2021 Q1	5/17/2021	43,905	0.0%	581,434	3/31/2021
2020 Q4	2/16/2021	60,878	0.0%	694,230	12/31/2020
2020 Q3	11/13/2020	51,921	0.0%	682,437	9/30/2020
2020 Q2	8/20/2020	76,769	0.0%	622,415	6/30/2020
2020 Q1	5/15/2020	50,416	0.0%	596,631	3/31/2020
2019 Q4	2/7/2020	48,665	0.0%	575,570	12/31/2019
2014 Q2	7/30/2014	12,713	0.0%	204,341	6/30/2014
2014 Q1	4/29/2014	13,246	0.0%	194,191	3/31/2014
2013 Q4	2/14/2014	12,434	0.0%	176,933	12/31/2013